株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液学的検査の世界市場:分析と予測 (2019-2029年)

Global Hematology Testing Market: Focus on Product Type, End-User, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029

発行 BIS Research Inc. 商品コード 917486
出版日 ページ情報 英文 254 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
血液学的検査の世界市場:分析と予測 (2019-2029年) Global Hematology Testing Market: Focus on Product Type, End-User, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029
出版日: 2019年11月18日 ページ情報: 英文 254 Pages
概要

世界の血液学的検査市場は、2018年に45億4,000万米ドルとなり、2029年までに82億米ドルへ拡大すると予測されています。

当レポートでは、世界の血液学的検査市場について調査し、世界市場の規模と成長予測、製品・エンドユーザー・地域別による分析と予測、競合情勢の分析、および主要企業のプロファイルなど、体系的な情報を提供しています。

917486_Figure 4 Global Hematology Testing Market Share (by Product Type), 2018 and 2029

エグゼクティブサマリー

第1章 製品定義

第2章 調査範囲

第3章 調査手法

第4章 世界の血液学的検査市場

  • 市場概要
  • 血液学のイントロダクション
  • 血液学的検査の重要性
  • 市場ダイナミクス
  • 世界市場のシナリオ
  • 予測の前提条件・制限事項

第5章 競合情勢

  • 概要
  • 主な発展・戦略
  • 市場シェア分析

第6章 産業考察

  • 血液システムの評価
  • 規制シナリオ
  • 主な産業考察

第7章 世界の血液学的検査市場:製品別

  • 概要
  • 装置・ソフトウェア
  • 消耗品

第8章 世界の血液学的検査市場:エンドユーザー別

  • 概要
  • 病院
  • 臨床検査ラボ
  • 研究機関
  • 患者による自己検査
  • その他

第9章 世界の血液学的検査市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第10章 企業プロファイル

  • 概要
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Danaher Corporation
  • Drew Scientific Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd
  • 堀場製作所
  • Mindray Medical International Limited
  • 日本光電
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Transasia Bio-Medicals Ltd.
図表

List of Tables

  • Table 1: Global Hematology Testing Market, 2018 and 2029
  • Table 2: Impact Analysis of Market Drivers
  • Table 3: Impact Analysis of Market Challenges
  • Table 4.1: Common Hematology Tests and Uses
  • Table 6.1: Guidelines Under ISLH
  • Table 6.2: Regulatory Authorities/Associations/Consortiums of the Global Hematology Testing Market
  • Table 7.1: Examples of Hematology Analyzers Offered by Key Companies of Hematology Testing Market
  • Table 7.2: Examples of Hematology Reagents Offered by Key Companies of Hematology Testing Market
  • Table 7.3: Examples of Stains, Controls, and Calibrators Offered by Key Companies of Hematology Testing Market
  • Table 9.1: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the U.S. for the Time Period between 2010 and 2017
  • Table 9.2: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the Canada between 2010 and 2017
  • Table 9.3: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the Germany for the Time Period between 2010 and 2017
  • Table 9.4: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in the U.K. for the Time Period between 2010 and 2017
  • Table 9.5: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in France between 2010 and 2017
  • Table 9.6: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in Italy for the Time Period between 2010 and 2017
  • Table 9.7: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in Japan for the Time Period between 2010 and 2017
  • Table 9.8: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in China for the Time Period between 2010 and 2017
  • Table 9.9: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in India for the Time Period between 2010 and 2017
  • Table 9.10: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in Australia for the Time Period between 2010 and 2017
  • Table 9.11: Number of Deaths, Incidence, and Prevalence of Common Hematologic Diseases in South Korea for the Time Period between 2010 and 2017

List of Figures

  • Figure 1: Global Hematology Testing Market Segmentation, 2018 and 2029
  • Figure 2: Share of Key Developments and Strategies, January 2016-July 2019
  • Figure 3: Global Hematology Testing Market Share (by Company), 2018
  • Figure 4: Global Hematology Testing Market Share (by Product Type), 2018 and 2029
  • Figure 5: Global Hematology Testing Market Share (by End User), 2018 and 2029
  • Figure 6: Global Hematology Testing Market Share (by Region), 2018 and 2029
  • Figure 2.1: Global Hematology Testing Market Segmentation
  • Figure 3.1: Global Hematology Testing Market Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Bottom-up Approach (Segment-wise Analysis)
  • Figure 3.6: Top-Down Approach (Segment-wise Analysis)
  • Figure 3.7: Assumptions and Limitations
  • Figure 4.1: Drivers and Challenges of the Global Hematology Testing Market
  • Figure 4.2: Global Hematology Testing Market, 2018-2029
  • Figure 5.1: Competitive Landscape (January 2016-September- 2019)
  • Figure 5.2: Share of Key Developments and Strategies, January 2016-September 2019
  • Figure 5.3: Product Launches and Developments (by Company), January 2016 and September 2019
  • Figure 5.4: Product Approvals and Certifications (by Company), January 2016 and September 2019
  • Figure 5.5: Collaborations, Partnerships, and Joint Ventures (by Company), January 2016 and September 2019
  • Figure 5.6: Business Expansions (by Company), January 2016 and September 2019
  • Figure 5.7: Market Share Analysis of Global Hematology Testing Market, 2017 and 2018
  • Figure 7.1: Global Hematology Testing Market Segmentation (by Product Type)
  • Figure 7.2: Global Hematology Testing Market (by Product), 2018-2029
  • Figure 7.3: Global Hematology Testing Market (by Instrument and Software), 2018-2029
  • Figure 7.4: Global Hematology Testing Market (Hematology Analyzer and Software), 2018-2029
  • Figure 7.5: Global Hematology Testing Market (Image Analyzer and Cell Counter), 2018-2029
  • Figure 7.6: Global Hematology Testing Market (Flow Cytometer), 2018-2029
  • Figure 7.7: Global Hematology Testing Market (Others), 2018-2029
  • Figure 7.8: Global Hematology Testing Market (by Consumable), 2018-2029
  • Figure 7.9: Global Hematology Testing Market (Hematology Reagents), 2018-2029
  • Figure 7.10: Global Hematology Testing Market (Flow Cytometry Reagents), 2018-2029
  • Figure 7.11: Global Hematology Testing Market (Stains, Controls, and Calibrators Reagents), 2018-2029
  • Figure 8.1: Global Hematology Testing Market Segmentation (by End User)
  • Figure 8.2: Global Hematology Testing Market (by End User), 2018-2029
  • Figure 8.3: Global Hematology Testing Market (Hospitals), 2018-2029
  • Figure 8.4: Global Hematology Testing Market (Clinical Testing Laboratories), 2018-2029
  • Figure 8.4: Global Hematology Testing Market (Research Institutes), 2018-2029
  • Figure 8.5: Global Hematology Testing Market (Patient Self-Testing), 2018-2029
  • Figure 8.6: Global Hematology Testing Market (Others), 2018-2029
  • Figure 9.1: Global Hematology Testing Market (by Region), 2018-2029
  • Figure 9.2: North America: Hematology Testing Market, 2018-2029
  • Figure 9.3: North America: Market Dynamics
  • Figure 9.4: North America: Hematology Testing Market (by Country), 2018-2029
  • Figure 9.5: U.S.: Hematology Testing Market, 2018-2029
  • Figure 9.6: Canada: Hematology Testing Market, 2018-2029
  • Figure 9.7: Europe: Hematology Testing Market, 2018-2029
  • Figure 9.8: Europe: Market Dynamics
  • Figure 9.9: Europe: Hematology Testing Market (by Country), 2018-2029
  • Figure 9.10: Germany: Hematology Testing Market, 2018-2029
  • Figure 9.11: U.K.: Hematology Testing Market, 2018-2029
  • Figure 9.12: France: Hematology Testing Market, 2018-2029
  • Figure 9.13: Italy: Hematology Testing Market, 2018-2029
  • Figure 9.14: Rest-of-Europe: Hematology Testing Market, 2018-2029
  • Figure 9.15: Asia-Pacific: Hematology Testing Market, 2018-2029
  • Figure 9.16: Asia-Pacific: Market Dynamics
  • Figure 9.17: Asia-Pacific: Hematology Testing Market (by Country), 2018-2029
  • Figure 9.18: Japan: Hematology Testing Market, 2018-2029
  • Figure 9.19: China: Hematology Testing Market, 2018-2029
  • Figure 9.20: India: Hematology Testing Market, 2018-2029
  • Figure 9.21: Australia: Hematology Testing Market, 2018-2029
  • Figure 9.22: South Korea: Hematology Testing Market, 2018-2029
  • Figure 9.23: Rest-of-Asia-Pacific: Hematology Testing Market, 2018-2029
  • Figure 9.24: Rest-of-the-World: Hematology Testing Market, 2018-2029
  • Figure 9.25: Rest-of-the-World: Market Dynamics
  • Figure 10.1: Shares of Key Company Profiles
  • Figure 10.2: Abbott Laboratories: Product Portfolio for Global Hematology Testing Market
  • Figure 10.3: Abbott Laboratories: Overall Financials, 2016-2018
  • Figure 10.4: Abbott Laboratories: Revenue (by Business Segment), 2016-2018
  • Figure 10.5: Abbott Laboratories: Revenue (by Region), 2016-2018
  • Figure 10.6: Abbott Laboratories: R&D Expenditure (2016-2018)
  • Figure 10.7: Abbott Laboratories: SWOT Analysis
  • Figure 10.8: Agilent Technologies, Inc.: Product Portfolio for Global Hematology Testing Market
  • Figure 10.9: Agilent Technologies, Inc.: Overall Financials, 2016-2018
  • Figure 10.10: Agilent Technologies, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.11: Agilent Technologies, Inc.: (by Region), 2016-2018
  • Figure 10.12: Agilent Technologies, Inc.: R&D Expenditure (2016-2018)
  • Figure 10.13: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 10.14: Bio-Rad Laboratories, Inc.: Product Portfolio for Global Hematology Testing Market
  • Figure 10.15: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
  • Figure 10.16: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.17: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.18: Bio-Rad Laboratories, Inc.: R&D Expenditure (2016-2018)
  • Figure 10.19: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 10.20: Boule Diagnostics AB: Product Portfolio for Global Hematology Testing Market
  • Figure 10.21: Boule Diagnostics AB: Overall Financials, 2016-2018
  • Figure 10.22: Boule Diagnostics AB: Revenue (by Business Segment), 2016-2018
  • Figure 10.23: Boule Diagnostics AB: Revenue (by Region), 2016-2018
  • Figure 10.24: Boule Diagnostics AB: R&D Expenditure (2016-2018)
  • Figure 10.25: Boule Diagnostics AB: SWOT Analysis
  • Figure 10.26: Danaher Corporation: Product Portfolio for Global Hematology Testing Market
  • Figure 10.27: Danaher Corporation: Overall Financials, 2016-2018
  • Figure 10.28: Danaher Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 10.29: Danaher Corporation: Revenue (by Region), 2016-2018
  • Figure 10.30: Danaher Corporation: R&D Expenditure (2016-2018)
  • Figure 10.31: Danaher Corporation: SWOT Analysis
  • Figure 10.32: Drew Scientific Inc.: Product Portfolio for Global Hematology Testing Market
  • Figure 10.33: Drew Scientific Inc.: SWOT Analysis
  • Figure 10.34: EKF Diagnostics Holdings plc: Product Portfolio for Global Hematology Testing Market
  • Figure 10.35: EKF Diagnostics Holdings plc: Overall Financials, 2016-2018
  • Figure 10.36: EKF Diagnostics Holdings plc: Revenue (by Business Segment), 2016-2018
  • Figure 10.37: EKF Diagnostics Holdings plc: (by Region), 2016-2018
  • Figure 10.38: EKF Diagnostics Holdings plc: R&D Expenditure (2016-2018)
  • Figure 10.39: EKF Diagnostics Holdings plc: SWOT Analysis
  • Figure 10.40: F. Hoffmann-La Roche Ltd: Product Portfolio for Global Hematology Testing Market
  • Figure 10.41: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
  • Figure 10.42: F. Hoffmann-La Roche Ltd: Revenue (by Business Segment), 2016-2018
  • Figure 10.43: F. Hoffmann-La Roche Ltd: (Revenue by Diagnostics Segment), 2016-2018
  • Figure 10.44: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016-2018
  • Figure 10.45: F. Hoffmann-La Roche Ltd: R&D Expenditure (2016-2018)
  • Figure 10.46: F. Hoffmann-La Roche Ltd: SWOT Analysis
  • Figure 10.47: HORIBA, Ltd.: Product Portfolio for Global Hematology Testing Market
  • Figure 10.48: HORIBA, Ltd.: Overall Financials, 2016-2018
  • Figure 10.49: HORIBA, Ltd.: Revenue (by Business Segment), 2016-2018
  • Figure 10.50: HORIBA, Ltd.: Medical-Diagnostic Instruments & Systems Revenue (by Region), 2016-2018
  • Figure 10.51: HORIBA, Ltd.: R&D Expenditure (2016-2018)
  • Figure 10.52: HORIBA, Ltd.: SWOT Analysis
  • Figure 10.53: Mindray Medical International Limited: Product Portfolio for Global Hematology Testing Market
  • Figure 10.54: Mindray Medical International Limited: SWOT Analysis
  • Figure 10.55: Nihon Kohden Corporation: Product Portfolio for Global Hematology Testing Market
  • Figure 10.56: Nihon Kohden Corporation: Overall Financials, 2016-2018
  • Figure 10.57: Nihon Kohden Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 10.58: Nihon Kohden Corporation: Revenue (by Region), 2016-2018
  • Figure 10.59: Nihon Kohden Corporation: R&D Expenditure (2016-2018)
  • Figure 10.60: Nihon Kohden Corporation: SWOT Analysis
  • Figure 10.61: Siemens Healthineers AG: Product Portfolio for Global Hematology Testing Market
  • Figure 10.62: Siemens Healthineers AG: Overall Financials, 2016-2018
  • Figure 10.63: Siemens Healthineers AG: Revenue (by Business Segment), 2016-2018
  • Figure 10.64: Siemens Healthineers AG: Revenue (by Region), 2016-2018
  • Figure 10.65: Siemens Healthineers AG: R&D Expenditure (2016-2018)
  • Figure 10.66: Siemens Healthineers AG: SWOT Analysis
  • Figure 10.67: Sysmex Corporation: Product Portfolio for Global Hematology Testing Market
  • Figure 10.68: Sysmex Corporation: Overall Financials, 2016-2018
  • Figure 10.69: Sysmex Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 10.70: Sysmex Corporation: Revenue (by Region), 2016-2018
  • Figure 10.71: Sysmex Corporation: R&D Expenditure (2016-2018)
  • Figure 10.72: Sysmex Corporation: SWOT Analysis
  • Figure 10.73: Thermo Fisher Scientific Inc.: Product Portfolio for Global Hematology Testing Market
  • Figure 10.74: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 10.75: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.76: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 10.77: Thermo Fisher Scientific Inc.: R&D Expenditure (2016-2018)
  • Figure 10.78: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 10.79: Transasia Bio-Medicals Ltd.: Product Portfolio for Global Hematology Testing Market
  • Figure 10.80: Transasia Bio-Medicals Ltd.: SWOT Analysis
目次
Product Code: BH172A

Global Hematology Testing Market to Reach $8.20 Billion by 2029, Reports BIS Research

Key Questions Answered in this Report:

  • What is the importance of hematology testing and what are the products involved in hematology testing?
  • What are the key trends of the global hematology testing market? How is the market evolving and what is its future scope?
  • What are the major drivers, challenges, and opportunities of the global hematology testing market?
  • What are the key developmental strategies implemented by the key players of the global hematology testing market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
  • Which are the key companies offering hematology products in the market or have their products in the pipeline? Which are the leading companies dominating the global hematology testing market? What was the market share of each of the key players of the global hematology testing market in 2017 and 2018?
  • What is the regulatory scenario of the global hematology testing market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of hematology testing products?
  • What was the market size of the global hematology testing market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global hematology testing market during the time period between 2019 and 2029?
  • What are the different instruments and consumables involved in hematology testing? Which instrument type and consumable dominate the market in 2018 and why? Which instrument and consumable are expected to witness highest growth rate and to dominate in market in 2029?
  • What are the different end-users of the global hematology testing market? Which end-user type dominates the market in 2018 and is expected to dominate in 2029?
  • What was the market value of the leading segments and sub-segments of the global hematology testing market? What are the different macro and micro factors influencing the growth of the market?
  • How is the industry expected to evolve during the forecast period 2019-2029? How is each segment of the global hematology market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2029?
  • Which region is expected to contribute the highest sales of the global hematology testing market during the time period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different hematology testing products? What are the leading countries of different regions that contribute significantly toward the growth of the hematology testing market?
  • What are the key players of the global hematology testing market and what is their role in the market?

Overview on the Global Hematology Testing Market

The ability of hematology test to effectively measure several blood components has made it an essential screening tool to diagnose a wide range of blood-related disorders, including anemia, blood cancer, hemorrhagic conditions, and blood infections, among others that affect millions of people each year across all age groups. Increasing incidences of hematology disorders and growing awareness related to the availability of wide range of diagnostic option to treat these targeted disorders are the primary factors driving the growth of the hematology testing market. Automation, being the primary focus of the hematology testing, the market has been witnessing considerable technological advancements with respect to products that offer effective, accurate, and fast testing results. The availability of automated hematology analyzers has further led to reduced administrative error, making the process more effective and efficient in disease diagnosis, as compared to manual hematology testing. The market also witnesses a paradigm shift toward patient-self-testing that eliminates the requirement to travel to a lab, clinic or physicians' office for having the tests done. With the emergence of high throughput hematology analyzers and point-of-care devices, more companies are expected to enter into the market, investing more in its research and development with an effort to develop cost-effective and advanced hematology systems.

Global Hematology Testing Market Forecast, 2019-2029

The global hematology testing market was valued to be $4.54 billion in 2018 and is anticipated to witness an impressive single-digit growth rate, to reach $8.20 billion by 2029.

Expert Quote

"Technological advancements in hematology products and the need to develop sophisticated analyzers are propelling huge research activities by established players to develop innovative product lines. Most of the companies in the industry are working toward developing compact, user-friendly, and accurate hematology analyzers that are efficient and provide fast results. The advent of point-of-care hematology testing equipment is also expected to bring about a boom in the market in the upcoming years"

Scope of the Global Hematology Testing Market

The report constitutes of an in-depth study of the global hematology testing market, including a thorough analysis of the types of products. The study also presents a detailed analysis of the market dynamics and the estimation of the market size over the forecast period 2019-2029. The scope of this report is focused on the different products of Global Hematology Testing, and end-users as well as country-wise analysis.

The purpose of the study is to gain a holistic view of the global hematology testing market in terms of various factors influencing it, including regulatory reforms and technological advancements. The market has been segmented into 'product type', 'end-user', and 'region'. The scope of this report is centered upon conducting a detailed study of the products allied with the global hematology testing market. In addition, the study also includes exhaustive information on the unmet needs, new products, competitive landscape, market share of leading manufacturers, growth potential of each product, application, nature, technology and region, as well as other vital information with respect to the global hematology testing market.

Market Segmentation

By Product Type

Instruments and Software

  • Hematology Analyzer and Software
  • Flow Cytometer
  • Image Analyzer and Cell Counter
  • Others

Consumables

  • Hematology Reagents
  • Flow Cytometry Reagents
  • Stains, Controls and Calibrators

By End User

  • Hospitals
  • Clinical Testing Laboratories
  • Research Institutions
  • Patient Self-Testing
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

Key Companies of the Global Hematology Testing Industry

The key players contributing to the global hematology testing market are Abbott laboratories, Agilent Technologies, Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Danaher Corporation, Drew Scientific, EKF Diagnostics, F. Hoffmann-La Roche Ltd, HORIBA, Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd.

Table of Contents

Executive Summary

1 Product Definition

2 Scope of the Work

  • 2.1 Overview: Report Scope
  • 2.2 Segmentation of the Global Hematology Testing Market
  • 2.3 Assumptions and Limitations
  • 2.4 Key Questions Answered in the Report
  • 2.5 Base Year and Forecast Period

3 Research Methodology

  • 3.1 Overview: Report Methodology

4 Global Hematology Testing Market

  • 4.1 Market Overview
  • 4.2 Introduction to Hematology
  • 4.3 Importance of Hematology Testing
  • 4.4 Market Dynamics
  • 4.5 Global Market Scenario
  • 4.6 Assumptions and Limitations

5 Competitive Landscape

  • 5.1 Overview
  • 5.2 Key Developments and Strategies
    • 5.2.1 Product Launch and Development
    • 5.2.2 Product Approvals and Certifications
    • 5.2.3 Collaborations, Partnerships, and Joint Ventures
    • 5.2.4 Business Expansions and Acquisitions
    • 5.2.5 Others
  • 5.3 Market Share Analysis

6 Industry Insights

  • 6.1 Validation of Hematology Systems
  • 6.2 Regulatory Scenario
  • 6.3 Key Industry Insight
    • 6.3.1 Paradigm Shift toward Putting Hematology Analyzers on Lease instead of Sale

7 Global Hematology Testing Market (by Product)

  • 7.1 Overview
  • 7.2 Instruments and Software
    • 7.2.1 Hematology Analyzer and Software
    • 7.2.2 Image Analyzer and Cell Counter
    • 7.2.3 Flow Cytometer
    • 7.2.4 Others
  • 7.3 Consumables
    • 7.3.1 Hematology Reagents
    • 7.3.2 Flow Cytometry Reagents
    • 7.3.3 Stains, Controls, and Calibrators

8 Global Hematology Testing Market (by End User)

  • 8.1 Overview
  • 8.2 Hospitals
  • 8.3 Clinical Testing Laboratories
  • 8.4 Research Institutes
  • 8.5 Patient Self-Testing
  • 8.6 Others

9 Global Hematology Testing Market (by Region)

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 Overview
    • 9.2.2 U.S.
    • 9.2.3 Canada
  • 9.3 Europe
    • 9.3.1 Overview
    • 9.3.2 Germany
    • 9.3.3 U.K.
    • 9.3.4 France
    • 9.3.5 Italy
    • 9.3.6 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Overview
    • 9.4.2 Japan
    • 9.4.3 China
    • 9.4.4 India
    • 9.4.5 Australia
    • 9.4.6 South Korea
    • 9.4.7 Rest-of-Asia-Pacific
  • 9.5 Rest-of-the-World
    • 9.5.1 Overview

10 Company Profiles

  • 10.1 Overview
  • 10.2 Abbott Laboratories
    • 10.2.1 Company Overview
    • 10.2.2 Role of Abbott Laboratories in the Global Hematology Testing Market
    • 10.2.3 Financials
    • 10.2.4 SWOT Analysis
  • 10.3 Agilent Technologies, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of Agilent Technologies, Inc. in the Global Hematology Testing Market
    • 10.3.3 Financials
    • 10.3.4 SWOT Analysis
  • 10.4 Bio-Rad Laboratories, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Hematology Testing Market
    • 10.4.3 Financials
    • 10.4.4 SWOT Analysis
  • 10.5 Boule Diagnostics AB
    • 10.5.1 Company Overview
    • 10.5.2 Role of Boule Diagnostics AB in the Global Hematology Testing Market
    • 10.5.3 Financials
    • 10.5.4 SWOT Analysis
  • 10.6 Danaher Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Role of Danaher Corporation in the Global Hematology Testing Market
    • 10.6.3 Financials
    • 10.6.4 SWOT Analysis
  • 10.7 Drew Scientific Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Role of Drew Scientific Inc. in the Global Hematology Testing Market
    • 10.7.3 SWOT Analysis
  • 10.8 EKF Diagnostics Holdings plc
    • 10.8.1 Company Overview
    • 10.8.2 Role of EKF Diagnostics Holdings plc in the Global Hematology Testing Market
    • 10.8.3 Financials
    • 10.8.4 SWOT Analysis
  • 10.9 F. Hoffmann-La Roche Ltd
    • 10.9.1 Company Overview
    • 10.9.2 Role of F. Hoffmann-La Roche Ltd in the Global Hematology Testing Market
    • 10.9.3 Financials
    • 10.9.4 SWOT Analysis
  • 10.10 HORIBA, Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Role of HORIBA, Ltd. In the Global Hematology Testing Market
    • 10.10.3 Financials
    • 10.10.4 SWOT Analysis
  • 10.11 Mindray Medical International Limited
    • 10.11.1 Company Overview
    • 10.11.2 Role of Mindray Medical International Limited in the Global Hematology Testing Market
    • 10.11.3 SWOT Analysis
  • 10.12 Nihon Kohden Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Role of Nihon Kohden Corporation in the Global Hematology Testing Market
    • 10.12.3 Financials
    • 10.12.4 SWOT Analysis
  • 10.13 Siemens Healthineers AG
    • 10.13.1 Company Overview
    • 10.13.2 Role of Siemens Healthineers AG in the Global Hematology Testing Market
    • 10.13.3 Financials
    • 10.13.4 SWOT Analysis
  • 10.14 Sysmex Corporation
    • 10.14.1 Company Overview
    • 10.14.2 Role of Sysmex Corporation in the Global Hematology Testing Market
    • 10.14.3 Financials
    • 10.14.4 SWOT Analysis
  • 10.15 Thermo Fisher Scientific Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Role of Thermo Fisher Scientific Inc. in the Global Hematology Testing Market
    • 10.15.3 Financials
    • 10.15.4 SWOT Analysis
  • 10.16 Transasia Bio-Medicals Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Role of Transasia Bio-Medicals Ltd. In the Global Hematology Testing Market
    • 10.16.3 SWOT Analysis